Tectonic Therapeutic (TECX) Capital Expenditures (2017 - 2026)
Tectonic Therapeutic (TECX) reported Capital Expenditures of $19000.0 for Q1 2026, down 29.63% year-over-year from $27000.0 in Q1 2025, and down 89.5% quarter-over-quarter from $181000.0 in Q3 2025.
Tectonic Therapeutic (TECX) Capital Expenditures (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Capital Expenditures data on file, last reported at $19000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $19000.0, down 29.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $200000.0 (up 11.73% YoY), and the FY2025 annual result was $208000.0, up 33.33% from the prior year.
- Capital Expenditures retreated to $19000.0 in Q1 2026 per TECX's latest filing, from $181000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $267000.0 in Q4 2022 and troughed at -$181000.0 in Q3 2022.
- A 5-year average of $61933.3 and a median of $27000.0 in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures sank 167.79% in 2022, then jumped 2085.71% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $267000.0 in 2022, then sank by 81.27% to $50000.0 in 2023, then tumbled by 94.0% to $3000.0 in 2024, then surged by 5933.33% to $181000.0 in 2025, then sank by 89.5% to $19000.0 in 2026.
- Business Quant data shows TECX's Capital Expenditures at $19000.0 in Q1 2026, $181000.0 in Q3 2025, and $27000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,000.00 |
| Mar 31, 2026 | 19,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 153,000.00 |
| Sep 30, 2024 | 153,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 214,000.00 |